Sign In | Join Free | My
China Guangzhou Meisi New Material Co.,Ltd logo
Guangzhou Meisi New Material Co.,Ltd
Guangzhou Meisi New Material High quality, Best service, Reasonable price.
Verified Supplier

5 Years

Home > Active Pharmaceutical Ingredients >

20123-80-2 Calcium Dobesilate

Guangzhou Meisi New Material Co.,Ltd
Trust Seal
Verified Supplier
Credit Check
Supplier Assessment

20123-80-2 Calcium Dobesilate

  • 1
  • 2

Brand Name : Meisi New Material

Place of Origin : China

MOQ : 100000KG

Payment Terms : T/T

Delivery Time : 5-8 work days

Contact Now

Calcium dobesilate CAS No.20123-80-2

Product Name: Calcium dobesilate
Full English name:2,5-dihydroxy-benzenesulfonic aci calcium salt

Chemical name: Calcium 2,5-dihydroxybenzenesulfonate monohydrate

CAS No:20123-80-2
Molecular formula : 2C6H5O5S.Ca
Molecular weight : 418.41

Physical and chemical properties:

White odorless crystalline powder, soluble in water.

Product category

Calcium dobesilate (trade name: daoshengming, dobeside, anddoming, haochang, etc.), chemical name: 2,5-dihydroxybenzenesulfonate monohydrate. It is a selective vasodilator acting on the capillary wall. It can not only adjust and improve the permeability, chemical book and brittleness of capillary wall, but also inhibit bradykinin and other active substances. It is mainly used in the treatment of capillary diseases caused by various reasons, such as diabetic retinopathy, varicose veins, phlebitis, leg spasm, phlegm itching dermatitis and other diseases. It has high bioavailability, low toxicity and high therapeutic index. It is an ideal drug for the treatment of capillary diseases.

Product Tags:

active pharma ingredients


medicine active ingredient

China 20123-80-2 Calcium Dobesilate wholesale

20123-80-2 Calcium Dobesilate Images

Inquiry Cart 0
Send your message to this supplier
*To: Guangzhou Meisi New Material Co.,Ltd
Characters Remaining: (0/3000)

Home| Products| Suppliers| Quality Suppliers| Site Map |About Us |Contact Us |Help |关于我们 |联系我们

Copyright © 2009 - 2022 All rights reserved.